Neurotransmitter therapy and diet in malignant phenylketonuria.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007223:Infant; D007231:Infant, Newborn; D007980:Levodopa / Q000627:therapeutic use; D010649:Phenylalanine / Q000378:metabolism; D010661:Phenylketonurias / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*
D007980:Levodopa; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D006916:5-Hydroxytryptophan; D002230:Carbidopa; D006719:Homovanillic Acid